Pfizer, Shanghai Pharma sign MoU to expand business in China
The partnership is intended to leverage both companies’ strengths, matching Pfizer‘s global capabilities in developing medicines with Shanghai Pharmaceutical’s capabilities and reach in the China market. The companies
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.